The performance ceiling for non-invasive Brain-Computer Interfaces (BCIs) is rising dramatically, not from better sensors, but from advanced AI. New models can extract high-fidelity signals from noisy data collected outside the skull, potentially making surgical implants like Neuralink unnecessary for sophisticated use cases.

The company's next product will provide objective brain state data, much like a CGM provides constant glucose readings. This allows for data-driven mental health treatment, moving beyond subjective checklists and enabling closed-loop therapies with neuromodulators, fundamentally changing diagnostics and care.

Science Corp. developed a retinal prosthesis with a key innovation: the implant is made of tiny solar panels. It is powered entirely by the infrared image projected onto it from a pair of glasses, eliminating the need for internal batteries or external wires, a major hurdle for brain-computer interfaces.

Challenging Neuralink's implant-based BCI, Merge Labs is creating a new paradigm using molecules, proteins, and ultrasound. This less invasive approach aims for higher bandwidth by interfacing with millions of neurons, fundamentally rethinking how to connect brains to machines.

While current brain-computer interfaces (BCIs) are for medical patients, the timeline for healthy individuals to augment their brains is rapidly approaching. A child who is five years old today might see the first healthy human augmentations before they graduate high school, signaling a near-term, transformative shift for society.

While companies like Neuralink popularize assistive BCIs for controlling external devices, a different segment is focused on therapeutic applications. Companies like InBrain aim not to control computers but to use high-resolution interfaces to directly heal or modulate neural circuits for treating diseases.

A "frontier interface" is one where the interaction model is completely unknown. Historically, from light pens to cursors to multi-touch, the physical input mechanism has dictated the entire scope of what a computer can do. Brain-computer interfaces represent the next fundamental shift, moving beyond physical manipulation.

For decades, the efficacy of brain-computer interfaces (BCIs) has been hampered by metal electrodes that are too rigid for soft brain tissue. This mechanical mismatch causes chronic inflammation, scar tissue, and signal degradation, creating a significant obstacle for long-term therapeutic implants.

New artificial neurons operate at the same low voltage as human ones (~0.1 volts). This breakthrough eliminates the need for external power sources for prosthetics and brain interfaces, paving the way for seamless, self-powered integration of technology with the human body.